• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,151.45 964.58
( 1.25%)
Global Indices
Nasdaq
52,169.86 -404.11
(-0.77%)
Dow Jones
7,480.34 -74.43
(-0.99%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,574.52 2.28
(0.02%)
Forex
USD-INR
96.36 0.10
(0.10%)
EUR-INR
110.37 0.25
(0.23%)
GBP-INR
130.11 0.62
(0.47%)
JPY-INR
0.59 0.00
(0.06%)

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524636
INE102E01018
-11.542039
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
178.59
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

ptc india ltd
Antelopus Selan Energy standalone net profit rises 157.65% in the March 2026 quarter
May 05,2026
Net profit of Antelopus Selan Energy rose 157.65% to Rs 38.08 crore in the quarter ended March 2026 as against Rs 14.78 crore during the previous quarter ended March 2025. Sales rose 65.28% to Rs 102.01 crore in the quarter ended March 2026 as against Rs 61.72 crore during the previous quarter ended March 2025.

For the full year,net profit rose 26.98% to Rs 89.61 crore in the year ended March 2026 as against Rs 70.57 crore during the previous year ended March 2025. Sales rose 8.06% to Rs 278.88 crore in the year ended March 2026 as against Rs 258.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales102.0161.72 65 278.88258.08 8
OPM %56.5150.00 -56.8753.29 -
PBDT59.1933.60 76 166.76146.15 14
PBT50.4919.33 161 119.4494.85 26
NP38.0814.78 158 89.6170.57 27